EBITDA Margin
-485.52%
Quarterly · Period ending:
MRNA EBITDA Margin
Latest reported-485.52%period ending
Latest reported-485.52%period ending
MRNA Quarterly EBITDA Margin (-210.18% → -485.52%)
Quarterly ebitda margin
High-resolution chart · PNG
MRNA ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -485.5172% | |
| -323.3933% | |
| -107.9646% | |
| -13.2874% | |
| -535.2113% | |
| -863.5514% | |
| -116.9456% | |
| 4.2588% | |
| -557.4661% | |
| -672.4551% | |
| 9.8827% | |
| -92.7908% | |
| -477.907% | |
| -11.8607% | |
| 33.8901% | |
| 41.5528% | |
| 55.9571% | |
| 72.4916% | |
| 78.9754% | |
| 75.088% | |
| 74.4247% | |
| 73.3219% | |
| -45.5191% | |
| -140.2305% | |
| -160.7918% | |
| -1,371.4269% | |
| -807.3639% | |
| -671.882% | |
| -965.6577% | |
| -772.6678% | |
| -373.7416% | |
| -176.8566% | |
| -293.203% | |
| -231.3992% | |
| -39.0766% | |
| -147.7174% | |
| -210.1752% | |
| -210.1752% |